Assessment of Cytokines, microRNA and patient related outcome measures in Conversion Disorder/Functional Neurological Disorder (CD/FND): the CANDO clinical feasibility study

Christina Maria Van Der Feltz-Cornelis; Sally Brabyn; Jonathan  Ratcliff; Danielle Varley; Victoria Louise Allgar; Simon Gilbody; Chris Clarke; Dimitris Lagos

doi:10.1016/j.bbih.2021.100228

Assessment of Cytokines, microRNA and patient related outcome measures in Conversion Disorder/Functional Neurological Disorder (CD/FND): the CANDO clinical feasibility study

Christina Maria Van Der Feltz-Cornelis, Sally Brabyn, Jonathan Ratcliff, Danielle Varley, Victoria Louise Allgar, Simon Gilbody, Chris Clarke, Dimitris Lagos

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	100228
Number of pages	13
Journal	Brain, Behavior, & Immunity - Health
Volume	13
Early online date	24 Feb 2021
DOIs	https://doi.org/10.1016/j.bbih.2021.100228
Publication status	Published - 1 May 2021

Bibliographical note

Access to Document

10.1016/j.bbih.2021.100228

CANDO manuscript 1802021accepted version
This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy.
Accepted author manuscript, 93.6 KBLicence: CC BY-NC-ND
Assessment of cytokines, microRNA and patient related outcome measuresin conversion disorder/functional neurological disorder (CD/FND): TheCANDO clinical feasibility study
© 2021 The Authors
Final published version, 1.14 MBLicence: CC BY-NC-ND

Cite this

Van Der Feltz-Cornelis, C. M., Brabyn, S., Ratcliff, J., Varley, D., Allgar, V. L., Gilbody, S., Clarke, C., & Lagos, D. (2021). Assessment of Cytokines, microRNA and patient related outcome measures in Conversion Disorder/Functional Neurological Disorder (CD/FND): the CANDO clinical feasibility study. Brain, Behavior, & Immunity - Health, 13, [100228]. https://doi.org/10.1016/j.bbih.2021.100228

@article{82182f787ab14a6ea3ba7fff86fe4598,

title = "Assessment of Cytokines, microRNA and patient related outcome measures in Conversion Disorder/Functional Neurological Disorder (CD/FND): the CANDO clinical feasibility study",

author = "{Van Der Feltz-Cornelis}, {Christina Maria} and Sally Brabyn and Jonathan Ratcliff and Danielle Varley and Allgar, {Victoria Louise} and Simon Gilbody and Chris Clarke and Dimitris Lagos",

note = "{\textcopyright} 2021 The Authors ",

year = "2021",

month = may,

day = "1",

doi = "10.1016/j.bbih.2021.100228",

language = "English",

volume = "13",

journal = "Brain, Behavior, & Immunity - Health",

issn = "2666-3546",

publisher = "Elsevier Inc.",

}

Van Der Feltz-Cornelis, CM , Brabyn, S, Ratcliff, J, Varley, D, Allgar, VL , Gilbody, S, Clarke, C & Lagos, D 2021, 'Assessment of Cytokines, microRNA and patient related outcome measures in Conversion Disorder/Functional Neurological Disorder (CD/FND): the CANDO clinical feasibility study', Brain, Behavior, & Immunity - Health, vol. 13, 100228. https://doi.org/10.1016/j.bbih.2021.100228

Assessment of Cytokines, microRNA and patient related outcome measures in Conversion Disorder/Functional Neurological Disorder (CD/FND): the CANDO clinical feasibility study. / Van Der Feltz-Cornelis, Christina Maria ; Brabyn, Sally; Ratcliff, Jonathan et al.
In: Brain, Behavior, & Immunity - Health, Vol. 13, 100228, 01.05.2021.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Assessment of Cytokines, microRNA and patient related outcome measures in Conversion Disorder/Functional Neurological Disorder (CD/FND)

T2 - the CANDO clinical feasibility study

AU - Van Der Feltz-Cornelis, Christina Maria

AU - Brabyn, Sally

AU - Ratcliff, Jonathan

AU - Varley, Danielle

AU - Allgar, Victoria Louise

AU - Gilbody, Simon

AU - Clarke, Chris

AU - Lagos, Dimitris

PY - 2021/5/1

Y1 - 2021/5/1

U2 - 10.1016/j.bbih.2021.100228

DO - 10.1016/j.bbih.2021.100228

M3 - Article

SN - 2666-3546

VL - 13

JO - Brain, Behavior, & Immunity - Health

JF - Brain, Behavior, & Immunity - Health

M1 - 100228

ER -

Van Der Feltz-Cornelis CM , Brabyn S, Ratcliff J, Varley D, Allgar VL , Gilbody S et al. Assessment of Cytokines, microRNA and patient related outcome measures in Conversion Disorder/Functional Neurological Disorder (CD/FND): the CANDO clinical feasibility study. Brain, Behavior, & Immunity - Health. 2021 May 1;13:100228. Epub 2021 Feb 24. doi: 10.1016/j.bbih.2021.100228